Clinical Research Directory
Browse clinical research sites, groups, and studies.
SCLC Tarlatamab Blood Collection
Sponsor: Duke University
Summary
The overall objective of this project is to prospectively collect blood samples throughout treatment with tarlatamab in patients with small cell lung cancer (SCLC). These samples will then be analyzed through a variety of assays to better characterize tarlatamab in the real-world setting. The investigators will prospectively collect blood samples from 25 patients on days 1, 8, and 15 of tarlatamab treatment, as well as after each interval scan for disease monitoring. The investigators will also collect patient data including demographics and baseline characteristics, primary diagnosis, treatment history, and disease monitoring and progression.
Official title: Analysis of Blood Samples in Small Cell Lung Cancer Patients Treated With Tarlatamab
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
25
Start Date
2026-05
Completion Date
2028-12
Last Updated
2026-03-12
Healthy Volunteers
No